Real life treatment experience and outcome of consecutively hospitalised patients with SARS-CoV-2 pneumonia by Omicron-1 vs Delta variants.

Efthymia GiannitsiotiPanagiotis MavroudisIoannis SpeggosAntigoni KatsoulidouNikos PantazisTheodoros LoupisIoannis DaniilNektaria RekleitiSofia DamianidouChristina LoukaChrysanthi SidiropoulouGeorgios KranidiotisLemonia VelentzaAlexandra StamatiMaria KasidiarakiEfrosini EfstratiadiGaryfallia LinardakiGeorgios ChrysosOlympia ZarkotouKaterina ZoiKyriaki TryfinopoulouStyliani Gerakari

Published in: Infectious diseases (London, England) (2023)

In a COVID-19 department the severity of pneumonia that did not differ between Omicron-1 and Delta variants predicted mortality whilst remdesivir remained protective in all analyses. Death rates did not differ between SARS-CoV-2 variants. Vigilance and consistency with prevention and treatment guidelines for COVID-19 is mandatory regardless of the predominant SARS-CoV-2 variant.

Keyphrases

sars cov
respiratory syndrome coronavirus
copy number
coronavirus disease
type diabetes
gene expression
cardiovascular events
coronary artery disease
dna methylation
combination therapy
replacement therapy
extracorporeal membrane oxygenation